During the last session, Tempest Therapeutics Inc (NASDAQ:TPST)’s traded shares were 0.74 million, with the beta value of the company hitting -1.78. At the end
During the last session, Tempest Therapeutics Inc (NASDAQ:TPST)’s traded shares were 0.97 million, with the beta value of the company hitting -1.78. At the end
In the last trading session, 3.37 million shares of the Tempest Therapeutics Inc (NASDAQ:TPST) were traded, and its beta was -1.76. Most recently the company’s
In the last trading session, 2.39 million Tempest Therapeutics Inc (NASDAQ:TPST) shares changed hands as the company’s beta touched -1.73. With the company’s per share
In the last trading session, 2.07 million Tempest Therapeutics Inc (NASDAQ:TPST) shares changed hands as the company’s beta touched -1.74. With the company’s per share
In last trading session, Tempest Therapeutics Inc (NASDAQ:TPST) saw 1.84 million shares changing hands with its beta currently measuring -1.76. Company’s recent per share price
Tempest Therapeutics Inc (NASDAQ:TPST) has a beta value of -1.76 and has seen 2.02 million shares traded in the last trading session. The company, currently
During the last session, Tempest Therapeutics Inc (NASDAQ:TPST)’s traded shares were 2.08 million, with the beta value of the company hitting -1.83. At the end
In the last trading session, 4.69 million shares of the Tempest Therapeutics Inc (NASDAQ:TPST) were traded, and its beta was -1.83. Most recently the company’s
In the last trading session, 3.36 million shares of the Tempest Therapeutics Inc (NASDAQ:TPST) were traded, and its beta was -1.83. Most recently the company’s
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
